after passing toxicity and experimental therapeutic tests , four oxime cholinesterase reactivators [ pam ( pyridine aldoxime methiodide ) , pac ( pralidoxime , pyridine aldoxime methylchloride ) , tmb4 ( trimedoxime ) , and dmo4 ( obidoxime , toxogonin , luh6 ) ] were compared in clinical trials .
C0030020
oxime
C0041028
trimedoxime